CCI nod for Sun-Ranbaxy deal
Competition Commission of India (CCI) has approved the merger of Sun Pharma and Ranbaxy, with riders. The competition watchdog has said in its report had said that it evaluated 49 drugs of both the companies and they will have to sell assets of 7 drugs in order to not have a monopoly.
Other Daily Videos
Budget 2024: ET Now explains key parameters you need to keep an eye on
IMF raises India's FY25 GDP growth forecast to 6.5%
Cross-hospital cashless treatment is a major move: New India Assurance CMD
Zee Ent moves NCLT after Sony terminates merger deal
ED conducts searches at Essel Group office in Mumbai, probes employees
